Having demonstrated that pyroptosis occurs as a consequence of sevoflurane-mediated inflammation, we decided to explore whether caspase-1, the activation of which induces pyroptosis, affects the pathogenesis of tauopathies. This evidence concerns the gene CASP1 and tauopathy.